Lee Ainslie’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.21M Buy
102,208
+50,636
+98% +$2.2M 0.03% 52
2026
Q2
$2.2M Buy
51,572
+26,991
+110% +$1.21M 0.02% 73
2026
Q1
$1.18M Buy
+24,581
New +$1.15M 0.01% 127
2023
Q2
– Sell
-8,634
Closed -$470K – 533
2023
Q1
$470K Buy
8,634
+3,459
+67% +$168K 0.01% 288
2022
Q4
$251K Buy
+5,175
New +$227K 0.01% 336
2016
Q3
– Sell
-42,790
Closed -$1.79M – 152
2016
Q2
$1.79M Buy
+42,790
New +$1.75M 0.02% 89
2016
Q1
– Sell
-91,300
Closed -$3.89M – 149
2015
Q4
$3.89M Sell
91,300
-10,350
-10% -$476K 0.06% 38
2015
Q3
$4.82M Hold
101,650
– – 0.08% 33
2015
Q2
$5.04M Buy
+101,650
New +$5.15M 0.08% 37

Other funds holding SNY

Lee Ainslie's SNY Position: Q3 2026 in Review

Lee Ainslie increased its Sanofi (SNY) stake by 98% in Q3 2026, buying an estimated $2.2M and bringing the position to 102,208 shares worth $4.21M. The position accounts for 0.03% of the portfolio, ranked #52.

Lee Ainslie first reported a position in SNY in Q2 2015 and has held it in 9 quarters since. The position peaked at $5.04M in Q2 2015. 679 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • Lee Ainslie held 102,208 shares of Sanofi worth $4.21M as of Q3 2026.
  • Lee Ainslie bought 50,636 Sanofi shares in Q3 2026, an estimated $2.2M.
  • Sanofi made up 0.03% of Lee Ainslie's portfolio in Q3 2026, its #52 holding.
  • Lee Ainslie first reported a position in Sanofi in Q2 2015 and has held it in 9 quarters since.
  • Lee Ainslie's Sanofi position peaked at $5.04M in Q2 2015.
  • 679 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on Maverick Capital's 13F filing for Q3 2026, filed 16 Nov 2026.